KAPIL KUMAR

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease BOSTON, MA NPI 1972602282

General Payments — all program years on this page

$14,106.90

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,010.39 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,100.001
Food and Beverage $910.3917

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Abbott Laboratories $2,281.227
Biosense Webster, Inc. $528.749
BOSTON SCIENTIFIC CORPORATION $200.432

By program year

Program yearAmountRecords
2018 $849.528
2019 $223.522
2020 $225.001
2021 $8,964.622
2022 $82.201
2023 $751.658
2024 $3,010.3918

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077685077 Biosense Webster, Inc. $133.75 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077685090 Biosense Webster, Inc. $35.61 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077685156 Biosense Webster, Inc. $33.05 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077685276 Biosense Webster, Inc. $28.25 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077685530 Biosense Webster, Inc. $31.42 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077685973 Biosense Webster, Inc. $122.83 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077686126 Biosense Webster, Inc. $24.08 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077686207 Biosense Webster, Inc. $117.19 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077686304 Biosense Webster, Inc. $2.56 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092243888 Boston Scientific Corporation $26.03 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092243890 Boston Scientific Corporation $174.40 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365146 Abbott Laboratories $29.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365148 Abbott Laboratories $14.69 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365150 Abbott Laboratories $71.43 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365152 Abbott Laboratories $14.37 06/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365154 Abbott Laboratories $33.90 06/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125365156 Abbott Laboratories $17.83 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125445980 Abbott Laboratories $2,100.00 07/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.